SG170009A1 - Polypeptide markers for the diagnosis and evaluation of vascular diseases - Google Patents

Polypeptide markers for the diagnosis and evaluation of vascular diseases

Info

Publication number
SG170009A1
SG170009A1 SG201101212-7A SG2011012127A SG170009A1 SG 170009 A1 SG170009 A1 SG 170009A1 SG 2011012127 A SG2011012127 A SG 2011012127A SG 170009 A1 SG170009 A1 SG 170009A1
Authority
SG
Singapore
Prior art keywords
vascular diseases
diagnosis
evaluation
polypeptide markers
markers
Prior art date
Application number
SG201101212-7A
Other languages
English (en)
Inventor
Harald Mischak
Original Assignee
Mosaiques Diagnostics & Therap
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mosaiques Diagnostics & Therap filed Critical Mosaiques Diagnostics & Therap
Publication of SG170009A1 publication Critical patent/SG170009A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
SG201101212-7A 2005-11-30 2006-11-30 Polypeptide markers for the diagnosis and evaluation of vascular diseases SG170009A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005057382 2005-11-30
EP06120879 2006-09-19

Publications (1)

Publication Number Publication Date
SG170009A1 true SG170009A1 (en) 2011-04-29

Family

ID=38092603

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201101212-7A SG170009A1 (en) 2005-11-30 2006-11-30 Polypeptide markers for the diagnosis and evaluation of vascular diseases

Country Status (12)

Country Link
US (2) US20100126861A1 (fr)
EP (1) EP1955075A2 (fr)
JP (1) JP5165580B2 (fr)
KR (1) KR20080074190A (fr)
AU (1) AU2006319138B2 (fr)
BR (1) BRPI0619248A2 (fr)
CA (1) CA2631602A1 (fr)
EA (1) EA014529B1 (fr)
IL (1) IL191605A0 (fr)
NO (1) NO20082394L (fr)
SG (1) SG170009A1 (fr)
WO (1) WO2007063089A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2478377A2 (fr) * 2009-09-14 2012-07-25 Mosaiques Diagnostics And Therapeutics AG Polypeptide marqueur pour le diagnostic et l'évaluation de maladies vasculaires

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0206903B8 (pt) * 2002-12-20 2021-07-27 Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp método de prognóstico de uma predisposição para o desenvolvimento de hipertensão e lesões no coração, sistema nervoso, sistema vascular ou rins, e uso da isoforma de 90 kda da enzima conversora de angiotensina i no referido método
WO2004089184A2 (fr) * 2003-04-01 2004-10-21 Diadexus, Inc. Nouvelles utilisations de la lp-pla2 en combinaison pour evaluer le risque coronaire
WO2005031364A1 (fr) * 2003-09-23 2005-04-07 The General Hospital Corporation Criblage destiné à des troubles gestationnels

Also Published As

Publication number Publication date
BRPI0619248A2 (pt) 2011-09-20
KR20080074190A (ko) 2008-08-12
US20100126861A1 (en) 2010-05-27
WO2007063089A2 (fr) 2007-06-07
EP1955075A2 (fr) 2008-08-13
CA2631602A1 (fr) 2007-06-07
IL191605A0 (en) 2008-12-29
US20150247865A1 (en) 2015-09-03
AU2006319138A1 (en) 2007-06-07
EA014529B1 (ru) 2010-12-30
WO2007063089A3 (fr) 2008-01-17
JP2009521670A (ja) 2009-06-04
JP5165580B2 (ja) 2013-03-21
EA200801475A1 (ru) 2009-02-27
AU2006319138B2 (en) 2013-05-16
NO20082394L (no) 2008-08-26

Similar Documents

Publication Publication Date Title
WO2007016367A3 (fr) Procedes, kits, systemes et bases de donnees relatifs a des maladies neoplasiques
TW200636076A (en) Method for measuring resistance or sensitivity to docetaxel
WO2006134390A3 (fr) Methode destinee a diagnostiquer une maladie neurodegenerative
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
DE602006019128D1 (de) Moesin, caveolin 1 und yes-assoziiertes protein 1 als prädiktive marker der reaktion auf dasatinib bei brustkrebs
WO2004055519A3 (fr) Marqueurs specifiques pour le cancer du pancreas
EP2021794B8 (fr) Utilisation de la protéine s100a 12 en tant que marqueur du cancer du côlon et du rectum
WO2009113814A3 (fr) Marqueur protéique utilisé pour le diagnostic précoce du cancer du foie
DE602004016499D1 (de) Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
WO2011027310A8 (fr) Nouveaux marqueurs tumoraux
WO2007023191A3 (fr) Marqueurs polypeptidiques pour le diagnostic du cancer de la vessie
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
WO2011029954A3 (fr) Polypeptide marqueur pour le diagnostic et l'évaluation de maladies vasculaires
WO2006106129A3 (fr) Marqueurs polypeptidiques pour diagnostiquer le cancer de la prostate
WO2007056332A3 (fr) Diagnostic moleculaire de maladies auto-immunes
ATE406579T1 (de) Verfahren zur diagnose von tumoren
WO2008116178A3 (fr) Systèmes et procédés pour le diagnostic et le pronostic du cancer colorectal
WO2009047280A3 (fr) Marqueur polypeptidique pour le diagnostic du cancer de la prostate
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
SG170009A1 (en) Polypeptide markers for the diagnosis and evaluation of vascular diseases
ATE432469T1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs
WO2005029089A3 (fr) Methode de diagnostic d'endometriose ovarienne a l'aide d'une proteine tfpi-2
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome